Acute Coronary Syndrome Clinical Trials

Find Acute Coronary Syndrome Clinical Trials Near You

Effect of Fan Application in Preventing Ticagrelor-associated Dyspnea in Patients With Acute Coronary Syndrome.

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will be conducted in the coronary intensive care unit of Dr. Siyami Ersek Chest, Heart and Vascular Surgery Training and Research Hospital. It aims to investigate the effect of hand fan therapy on ticagrelor-associated dyspnea in patients receiving ticagrelor.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Between the ages of 18 and 65,

• No severe hearing and vision problems,

• Can speak and understand Turkish,

• Easy to communicate with,

• First-time sufferer of acute coronary syndrome (ACS) for the first time,

• Decided to start ticagrelor therapy,

• Able to adapt to treatment,

• Individuals who volunteered to participate in the research.

Locations
Other Locations
Turkey
İstanbul Üniversitesi-Cerrahapaşa
NOT_YET_RECRUITING
Istanbul
Sağlık Bilimleri Üniversitesi Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Eğitim Araştırma Hastanesi
RECRUITING
Istanbul
Contact Information
Primary
Emine Tuğba YORULMAZ, research assistant
tugbayoorlmz@gmail.com
+905556177281
Backup
Arzu ERKOÇ, Associate professor
arzu.erkochut@iuc.edu.tr
+905552735500
Time Frame
Start Date: 2025-03-15
Estimated Completion Date: 2026-01-30
Participants
Target number of participants: 110
Treatments
Active_comparator: Standard Care (Control Group)
Routine ward care including semi-Fowler position and breathing exercises. Standard institutional care will be applied. Presence, number, and severity of dyspnea attacks will be recorded during the first 2 hours after ticagrelor administration.
Experimental: Standard Care + Fan Therapy (Experimental Group)
In addition to standard care, patients will undergo hand fanning for 5 minutes at 30, 60, and 120 minutes after ticagrelor administration. The fan will be directed toward the patient's face from a distance of \~15 cm. Dyspnea severity and number of episodes will be recorded during this period.~Device: Hand Fan
Related Therapeutic Areas
Sponsors
Leads: Acibadem University

This content was sourced from clinicaltrials.gov